Project Details
Description
F2 Isoprostane as a indicator of Oxidative Stress and PAH in Scleroderma
Status | Finished |
---|---|
Effective start/end date | 10/15/07 → 10/31/08 |
Funding
- ACTELION PHARMACEUTICALS LTD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.